This is apparent in immunohistochemical staining of hippocampal neurons and western blot of nuclear fractions from frontal cortex homogenates [36], suggesting Nrf2 activity is decreased in Alzheimer’s disease. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.